Solving Biofilm technology challenges in a rapid growing industry
We don't make the antimicrobials you use, we make the antimicrobials you use 1000 times more efficient.
Company Specialization
Biofilm Research and Development
For the reduction to practice of novel antibiofilm technologies for the control of biofilms in medicine, institutional facilities, industry and the household.
Biofilm Testing Services
Testing of proprietary and non-proprietary anti-biofilm technologies for companies and industries involved in biofilm control.
Biofilm Control Technologies
The development of novel ant-biofilm technologies for licensing or contract manufacturing for medical, institutional, industrial and household applications.
Business Opportunity
Our company started working with topical wound applications by developing an antimicrobial ointment and we intend to move on to development of treatments for acne vulgaris and then to surface disinfectants, all formulated using our biofilm dispersion inducer.
Currently we are working on an antimicrobial wound dressing that prevents, treats and eliminates biofilm infections of topical wounds. The initial product offering is expected to be an adhesive bandage incorporating our powerful and proprietary anti-biofilm formulation with one or more currently available antimicrobial combinations sold directly to health care providers and institutions for clinical use. We also plan to offer an OTC adhesive bandage to consumers for day-to-day wound care.
Customer Reach
- General Public
- Healthcare Facilities
- Geriatric Facilities
- Hospitals
- Pharmacies
- Schools
Company Specialization
Excelsior biofilms was founded by 3 established Ph.D. researchers with over 50 years of combined experience in the study of biofilms and biofilm control.
Our team has:
- A track record of securing funding from both industry and the government, with over 4 million dollars in research funding over the past 15 years.
- Publications in Science, PNAS, mBio, Scientific Reports, Frontiers in Microbiology, PLoS Pathogens, Molecular Microbiology, Journal of Bacteriology, Journal of Applied and Environmental Microbiology, Journal of Antimicrobial Chemotherapy, Journal of The Royal Society Interface, and others.
- Patents on three technology platforms with US and International coverage.